(Q38056365)

27 August 2017

title

Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy (English)

1 reference

27 August 2017

1 reference

hepatocellular carcinoma

1 reference

Nathalie Schmidt

1

1 reference

27 August 2017

Christoph Neumann-Haefelin

series ordinal

2

1 reference

27 August 2017

Robert Thimme

series ordinal

3

1 reference

27 August 2017

publication date

24 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

483-491

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

27 August 2017

cites work

1 reference

Global cancer statistics in the year 2000.

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Human tumor antigens recognized by T cells

21 January 2018

1 reference

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

21 January 2018

1 reference

Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity

21 January 2018

1 reference

Class I MHC presentation of exogenous antigens

21 January 2018

1 reference

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.

21 January 2018

1 reference

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.

21 January 2018

1 reference

Alpha-fetoprotein: a review

21 January 2018

1 reference

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

Potential of immunotherapy for hepatocellular carcinoma.

21 January 2018

1 reference

Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma

21 January 2018

1 reference

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

21 January 2018

1 reference

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

21 January 2018

1 reference

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

21 January 2018

1 reference

The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients

21 January 2018

1 reference

Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

The three Es of cancer immunoediting

21 January 2018

1 reference

Antigen-presenting cell function in the tolerogenic liver environment.

21 January 2018

1 reference

Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

21 January 2018

1 reference

CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.

21 January 2018

1 reference

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

Cancer immunotherapy comes of age

21 January 2018

1 reference

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients

21 January 2018

1 reference

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

21 January 2018

1 reference

Overall survival and PD-L1 expression in metastasized malignant melanoma

21 January 2018

1 reference

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis

21 January 2018

1 reference

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

21 January 2018

1 reference

Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.

21 January 2018

1 reference

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Antigens for cancer immunotherapy.

21 January 2018

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

Regulatory T cells: overcoming suppression of T-cell immunity

21 January 2018

1 reference

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

21 January 2018

1 reference

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

21 January 2018

1 reference

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

Analysis of CD4+ T-Cell Responses to a Novel -Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

21 January 2018

1 reference

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

21 January 2018

1 reference

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

21 January 2018

1 reference

Increased Immunostimulatory Activity Conferred to Antigen-presenting Cells by Exposure to Antigen Extract From Hepatocellular Carcinoma After Radiofrequency Thermal Ablation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341697

1 reference

27 August 2017

1 reference